- Home
- AIOT vs PALI Comparison
AIOT vs PALI Comparison
Compare AIOT & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIOT | PALI |
|---|---|---|
| Founded | 1993 | 1996 |
| Country | United States | United States |
| Employees | 1954 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 434.6M | 359.7M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | AIOT | PALI |
|---|---|---|
| Price | $3.74 | $1.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $10.33 | ★ $11.29 |
| AVG Volume (30 Days) | 1.9M | ★ 2.4M |
| Earning Date | 06-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | $24.46 | N/A |
| Revenue Next Year | $9.01 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $2.78 | $0.55 |
| 52 Week High | $5.88 | $2.86 |
Technical Indicators
Market Signals| Indicator | AIOT | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 46.05 | 50.65 |
| Support Level | $3.66 | $1.57 |
| Resistance Level | $5.69 | $2.17 |
| Average True Range (ATR) | 0.26 | 0.12 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 6.94 | 60.26 |
Price Performance
Historical ComparisonAbout AIOT PowerFleet Inc.
PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.